Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viking Therapeutics (VKTX) Exchange Rate Effect (2022 - 2026)

Viking Therapeutics (VKTX) has disclosed Exchange Rate Effect for 5 consecutive years, with $16000.0 as the latest value for Q1 2026.

  • For Q1 2026, Exchange Rate Effect rose 1500.0% year-over-year to $16000.0; the TTM value through Mar 2026 reached $7000.0, up 107.07%, while the annual FY2025 figure was -$8000.0, 94.59% up from the prior year.
  • Exchange Rate Effect hit $16000.0 in Q1 2026 for Viking Therapeutics, up from $9000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $141000.0 in Q4 2022 and bottomed at -$223000.0 in Q3 2022.
  • Average Exchange Rate Effect over 5 years is -$16800.0, with a median of -$6000.0 recorded in 2025.
  • Year-over-year, Exchange Rate Effect tumbled 500.0% in 2025 and then surged 1500.0% in 2026.
  • Viking Therapeutics' Exchange Rate Effect stood at $141000.0 in 2022, then tumbled by 64.54% to $50000.0 in 2023, then crashed by 248.0% to -$74000.0 in 2024, then soared by 112.16% to $9000.0 in 2025, then soared by 77.78% to $16000.0 in 2026.
  • According to Business Quant data, Exchange Rate Effect over the past three periods came in at $16000.0, $9000.0, and -$6000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.